The involvement of purinergic receptors in the pathophysiology of inflammatory diseases is a recurring theme and has been studied in the context of inflammatory bowel disease (IBD) in conjunction with exploring the mechanisms of ATP release. This evidence concerns the gene P2RY1 and inflammatory bowel disease.